Personalis, Inc. - Common Stock (NQ:PSNL)

10.01 +0.40 (+4.16%)

Streaming Delayed Price Updated: 11:11 AM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 26, 2023

Via Benzinga

Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives

December 04, 2023

From Personalis, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 28, 2023

Via Benzinga

Personalis: Q3 Earnings Insights ↗

November 07, 2023

Via Benzinga

Earnings Outlook For Personalis ↗

November 06, 2023

Via Benzinga

Analyst Ratings for Personalis ↗

May 04, 2023

Via Benzinga

Recap: Personalis Q1 Earnings ↗

May 03, 2023

Via Benzinga

Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing

November 28, 2023

From Personalis, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 08, 2023

Via Benzinga

Personalis Reports Third Quarter 2023 Financial Results

November 07, 2023

From Personalis, Inc.

Via Business Wire

Personalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer

October 26, 2023

From Personalis, Inc.

Via Business Wire

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

Personalis to Announce Third Quarter 2023 Financial Results

October 24, 2023

From Personalis, Inc.

Via Business Wire

Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology

October 21, 2023

From Personalis, Inc.

Via Business Wire

Personalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023

October 19, 2023

From Personalis, Inc.

Via Business Wire

Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance

October 18, 2023

From Personalis, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

September 29, 2023

Friday's session saw 112 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 15, 2023

Friday's session saw 169 companies set new 52-week lows.

Via Benzinga

Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference

August 29, 2023

From Personalis, Inc.

Via Business Wire

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 24, 2023

From Personalis, Inc.

Via Business Wire

Personalis Reports Second Quarter 2023 Financial Results

August 08, 2023

From Personalis, Inc.

Via Business Wire

Personalis to Participate at Upcoming Investor Conferences

August 01, 2023

From Personalis, Inc.

Via Business Wire

Personalis to Announce Second Quarter 2023 Financial Results

July 25, 2023

From Personalis, Inc.

Via Business Wire

Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics

June 26, 2023

From Personalis, Inc.

Via Business Wire

Dr. Kenneth J. Widder Joins Personalis Board of Directors

June 13, 2023

From Personalis, Inc.

Via Business Wire

Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023

May 30, 2023

From Personalis, Inc.

Via Business Wire

Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer

May 16, 2023

From Personalis, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.